Aphtostomatitis and Mucositis Treatment by Natural Herbal Formula (Sorend®)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Hillel Yaffe Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
R&T Health Products Ltd.
Information provided by:
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT01321307
First received: March 22, 2011
Last updated: NA
Last verified: March 2011
History: No changes posted
  Purpose

Sorend is a water-based formula, which contains carob, melissa and sage. Elder inhabitants of Israel are known to use carob extract to ease sores in the mouth, due to the tannins which create a complex with various proteins and polysaccharides, thus creating an impenetrable layer covering the sores, allowing spontaneous healing.


Condition
Aphtostomatitis
Mucositis

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Aphtostomatitis and Mucositis Treatment by Natural Herbal Formula (Sorend®)

Further study details as provided by Hillel Yaffe Medical Center:

Estimated Enrollment: 120
Study Start Date: April 2011
Groups/Cohorts
Sorend
Group no. 1 shall receive Sorend following diagnosis of aphtostomatitis or mucositis.
Sorend placebo
Group no. 2 shall receive Sorend placebo following diagnosis of aphtostomatitis or mucositis.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Community population care

Criteria

Inclusion Criteria:

  • Herpetic aphtomatitis
  • Bacterial aphtostomatitis
  • Viral aphtostomatitis
  • Fungal aphtostomatitis

Exclusion Criteria:

  • Oncology patients
  • Systematic diseases (Colitis, Crohn, diabetes, Behcet)
  • Pregnancy
  • Arthritis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01321307

Contacts
Contact: Galit Avior, MD 972-4-630-4846

Locations
Israel
Hillel Yaffe MC, Otolaryngology - Head & Neck Surgery Unit Not yet recruiting
Hadera, Israel, 38100
Principal Investigator: Galit Avior, MD         
Sponsors and Collaborators
Hillel Yaffe Medical Center
R&T Health Products Ltd.
Investigators
Principal Investigator: Galit Avior, MD Hillel Yaffe Medical Center, Hadera, Israel
  More Information

No publications provided

Responsible Party: Galit Avior, MD, Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT01321307     History of Changes
Other Study ID Numbers: 91-2010-HYMC
Study First Received: March 22, 2011
Last Updated: March 22, 2011
Health Authority: Israel: Ministry of Health

Keywords provided by Hillel Yaffe Medical Center:
Aphtostomatitis
Mucositis
Mouth sores
Natural
Herbal

Additional relevant MeSH terms:
Mucositis
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Mouth Diseases
Stomatognathic Diseases

ClinicalTrials.gov processed this record on October 19, 2014